
Journal of Medicinal Chemistry p. 9742 - 9753 (2015)
Update date:2022-08-05
Topics:
Janssen, Freek J.
Baggelaar, Marc P.
Hummel, Jessica J. A.
Overkleeft, Herman S.
Cravatt, Benjamin F.
Boger, Dale L.
Van Der Stelt, Mario
Diacylglycerol lipase α (DAGLα) is responsible for the formation of the endocannabinoid 2-arachidonoylglycerol (2-AG) in the central nervous system. DAGLα inhibitors are required to study the physiological role of 2-AG. Previously, we identified the α-ketoheterocycles as potent and highly selective DAGLα inhibitors. Here, we present the first comprehensive structure-activity relationship study of α-ketoheterocycles as DAGLα inhibitors. Our findings indicate that the active site of DAGLα is remarkably sensitive to the type of heterocyclic scaffold with oxazolo-4N-pyridines as the most active framework. We uncovered a fundamental substituent effect in which electron-withdrawing meta-oxazole substituents increased inhibitor potency. (C6-C9)-acyl chains with a distal phenyl group proved to be the most potent inhibitors. The integrated SAR data was consistent with the proposed binding pose in a DAGLα homology model. Altogether, our results may guide the design of future DAGLα inhibitors as leads for molecular therapies to treat neuroinflammation, obesity, and related metabolic disorders.
View MoreJiangxi Global Natural Spice Co., Ltd.
website:https://www.jxhqxl.com/
Contact:+86-796-8106598
Address:No.89, Wenshan Road,South Industrial Park, Jishui County,Jiangxi Province
Jiangsu Willing Bio-Tech Co ltd
website:http://www.willingbio.com/
Contact:+86 18796908173
Address:No 18 Guoqiao Road
Weifang Adde Economic And Trade Co.,LTD.
Contact:86-536-8885548
Address:Room 1402,Wanda Plaza B Block,No.958,Yuanfei Road,Kuiwen District
Hangzhou Kai Peng Biotechnology Co., Ltd.
Contact:86-571-89939007
Address:NO. 499, Wensan West Road, Xihu District, Hangzhou, 310012, China
Chongqing Werlchem Fine Chemical Co. Ltd
Contact:+86-23-67521957
Address:NO.15,Fortune Road,Yubei District,401121,Chongqing,China
Doi:10.1021/jo00811a014
(1971)Doi:10.1039/j39710001875
(1971)Doi:10.1515/znb-2006-0510
(2006)Doi:10.1021/ja962606m
(1997)Doi:10.1080/10426500008043677
(2000)Doi:10.1021/acsmedchemlett.9b00233
(2019)